{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:44:33Z","timestamp":1793724273569,"version":"4.6.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["31003A_175656"],"award-info":[{"award-number":["31003A_175656"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,9,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Glioblastoma is the most aggressive primary brain tumor. Although temozolomide induces DNA damage, its efficacy is limited by intrinsic resistance mechanisms, leading to tumor relapse. In this study we aimed to identify microRNA-mediated resistance mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      MicroRNA screens were performed to identify temozolomide resistance mechanisms. Temozolomide response was evaluated using clonogenic and spheroid assays in glioblastoma cell lines\u00a0and patient-derived primary cells. DNA damage response was assessed by \u03b3H2AX foci formation. Cell cycle distribution, senescence and ferroptosis were assessed following\n                      <jats:italic>miR-19b<\/jats:italic>\n                      attenuation. An orthotopic xenograft and a syngeneic mouse model were used to confirm findings.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Our screen and subsequent phosphoprotein analysis identified\n                      <jats:italic>miR-19b<\/jats:italic>\n                      and its target PPP2R5E, a subunit of the phosphatase PP2A, as modulators of temozolomide response. Attenuation of\n                      <jats:italic>miR-19b<\/jats:italic>\n                      upregulated PPP2R5E, inducing genotoxic stress, thereby enhancing temozolomide response. Mechanistically, DNA damage correlated with elevated nuclear ROS, promoting senescence and ferroptosis. Consistently, pharmacological activation of PP2A with FTY720 phenocopied the effects of\n                      <jats:italic>miR-19b<\/jats:italic>\n                      suppression. Conversely, knockdown of PPP2R5E reversed temozolomide sensitisation in vitro, in vivo, and ex vivo models, confirming the critical role of the\n                      <jats:italic>miR-19b<\/jats:italic>\n                      \/PPP2R5E axis in modulating drug response.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Therapeutic targeting of the PPP2R5E\/PP2A complexes holds promise for enhanced temozolomide efficacy in glioblastoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41416-026-03474-2","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T12:56:26Z","timestamp":1779886586000},"page":"685-696","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting the miR-19b\/PPP2R5E axis enhances temozolomide response in glioblastoma via ROS-induced DNA damage"],"prefix":"10.1038","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4221-4926","authenticated-orcid":false,"given":"Elham","family":"Kashani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C.","family":"Sadowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaison","family":"Phour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hashemi Gheinani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristyna","family":"Hlavackova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Haemmig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Mueller-Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Trefny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Sharf Den Abu Fakher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelina","family":"Parvanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coline","family":"Nydegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theoni","family":"Maragkou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Schucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurel","family":"Perren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Zinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"L\u00fcdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Michael","family":"Marti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4918-6654","authenticated-orcid":false,"given":"Philippe","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Vassella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"3474_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO classification of tumors of the central nervous system: A summary. Neuro Oncol. 2021;23:1231\u201351.","journal-title":"Neuro Oncol"},{"key":"3474_CR2","doi-asserted-by":"publisher","first-page":"4070","DOI":"10.1158\/1078-0432.CCR-12-0560","volume":"18","author":"GJ Kitange","year":"2012","unstructured":"Kitange GJ, Mladek AC, Carlson BL, Schroeder MA, Pokorny JL, Cen L, et al. Inhibition of histone deacetylation potentiates the evolution of acquired temozolomide resistance linked to MGMT upregulation in glioblastoma xenografts. Clin Cancer Res. 2012;18:4070\u20139.","journal-title":"Clin Cancer Res"},{"key":"3474_CR3","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.21873\/anticanres.14073","volume":"40","author":"K Yamashiro","year":"2020","unstructured":"Yamashiro K, Nakao K, Ohba S, Hirose Y. Human Glioma Cells Acquire Temozolomide Resistance After Repeated Drug Exposure Via DNA Mismatch Repair Dysfunction. Anticancer Res. 2020;40:1315\u201323.","journal-title":"Anticancer Res"},{"key":"3474_CR4","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41586-020-2209-9","volume":"580","author":"M Touat","year":"2020","unstructured":"Touat M, Li YY, Boynton AN, Spurr LF, Iorgulescu JB, Bohrson CL, et al. Mechanisms and therapeutic implications of hypermutation in gliomas. Nature. 2020;580:517\u201323.","journal-title":"Nature"},{"key":"3474_CR5","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1158\/1541-7786.MCR-16-0125","volume":"14","author":"CR Gil Del Alcazar","year":"2016","unstructured":"Gil Del Alcazar CR, Todorova PK, Habib AA, Mukherjee B, Burma S. Augmented HR repair mediates acquired temozolomide resistance in glioblastoma. Mol Cancer Res. 2016;14:928\u201340.","journal-title":"Mol Cancer Res"},{"key":"3474_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04590-6","volume":"13","author":"X Zhang","year":"2022","unstructured":"Zhang X, Li T, Yang M, Du Q, Wang R, Fu B, et al. Acquired temozolomide resistance in MGMTlow gliomas is associated with regulation of homologous recombination repair by ROCK2. Cell Death Dis. 2022;13:138.","journal-title":"Cell Death Dis"},{"key":"3474_CR7","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41586-023-06678-1","volume":"623","author":"KR Taylor","year":"2023","unstructured":"Taylor KR, Barron T, Hui A, Spitzer A, Yal\u00e7in B, Ivec AE, et al. Glioma synapses recruit mechanisms of adaptive plasticity. Nature. 2023;623:366\u201374.","journal-title":"Nature"},{"key":"3474_CR8","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41586-022-05680-3","volume":"614","author":"E Karimi","year":"2023","unstructured":"Karimi E, Yu MW, Maritan SM, Perus LJM, Rezanejad M, Sorin M, et al. Single-cell spatial immune landscapes of primary and metastatic brain tumours. Nature. 2023;614:555\u201363.","journal-title":"Nature"},{"key":"3474_CR9","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1371\/journal.pone.0055665","volume":"8","author":"AV Knizhnik","year":"2013","unstructured":"Knizhnik AV, Roos WP, Nikolova T, Quiros S, Tomaszowski KH, Christmann M, et al. Survival and Death Strategies in Glioma Cells: Autophagy, Senescence and Apoptosis Triggered by a Single Type of Temozolomide-Induced DNA Damage. PLoS One. 2013;8:556\u201365.","journal-title":"PLoS One"},{"key":"3474_CR10","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.3390\/ijms23063231","volume":"23","author":"RI Peraza-Vega","year":"2022","unstructured":"Peraza-Vega RI, Valverde M, Rojas E. Interactions between miRNAs and Double-Strand Breaks DNA Repair Genes, Pursuing a Fine-Tuning of Repair. Int J Mol Sci. 2022;23:3231.","journal-title":"Int J Mol Sci"},{"key":"3474_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-024-06555-1","volume":"7","author":"T Stiff","year":"2024","unstructured":"Stiff T, Bayraktar S, Dama P, Stebbing J, Castellano L. CRISPR screens in 3D tumourspheres identified miR-4787-3p as a transcriptional start site miRNA essential for breast tumour-initiating cell growth. Commun Biol. 2024;7:1\u201311.","journal-title":"Commun Biol"},{"key":"3474_CR12","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3171\/2017.7.JNS17668","volume":"129","author":"MM Luedi","year":"2018","unstructured":"Luedi MM, Singh SK, Mosley JC, Hassan ISA, Hatami M, Gumin J, et al. Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma. J Neurosurg. 2018;129:1446\u201355.","journal-title":"J Neurosurg"},{"key":"3474_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.245","volume":"5","author":"S Haemmig","year":"2014","unstructured":"Haemmig S, Baumgartner U, Gl\u00fcck A, Zbinden S, Tschan MP, Kappeler A, et al. MiR-125b controls apoptosis and temozolomide resistance by targeting TNFAIP3 and NKIRAS2 in glioblastomas. Cell Death Dis. 2014;5:e1279.","journal-title":"Cell Death Dis"},{"key":"3474_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02542-9","volume":"9","author":"MP Hall","year":"2018","unstructured":"Hall MP, Woodroofe CC, Wood MG, Que I, Van\u2019t Root M, Ridwan Y, et al. Click beetle luciferase mutant and near infrared naphthyl-luciferins for improved bioluminescence imaging. Nat Commun. 2018;9:132.","journal-title":"Nat Commun"},{"key":"3474_CR15","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/978-1-4939-7659-1_15","volume":"1741","author":"JD Frenster","year":"2018","unstructured":"Frenster JD, Placantonakis DG. Bioluminescent In Vivo Imaging of Orthotopic Glioblastoma Xenografts in Mice. Methods Mol Biol. 2018;1741:191\u20138.","journal-title":"Methods Mol Biol"},{"key":"3474_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.bbamcr.2018.10.017","volume":"1866","author":"J Remy","year":"2019","unstructured":"Remy J, Linder B, Weirauch U, Konovalova J, Marschalek R, Aigner A, et al. Inhibition of PIM1 blocks the autophagic flux to sensitize glioblastoma cells to ABT-737-induced apoptosis. Biochim Biophys Acta - Mol Cell Res. 2019;1866:175\u201389.","journal-title":"Biochim Biophys Acta - Mol Cell Res"},{"key":"3474_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cpim.59","volume":"123","author":"C Humpel","year":"2018","unstructured":"Humpel C. Organotypic Brain Slice Cultures. Curr Protoc Immunol. 2018;123:1\u201317.","journal-title":"Curr Protoc Immunol"},{"key":"3474_CR18","doi-asserted-by":"crossref","unstructured":"Phour J., Vassella E. Methods in cancer research: Assessing therapy response of spheroid cultures by life cell imaging using a Cost-Effective Live-Dead Staining Protocol. Biol Methods Protoc. 2024;12:1\u20135.","DOI":"10.1093\/biomethods\/bpae060"},{"key":"3474_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-018-0781-5","volume":"17","author":"U Baumgartner","year":"2018","unstructured":"Baumgartner U, Berger F, Hashemi Gheinani A, Burgener SS, Monastyrskaya K, Vassella E. miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer. Mol Cancer. 2018;17:1\u201315.","journal-title":"Mol Cancer"},{"key":"3474_CR20","first-page":"noac265","volume":"16","author":"E Kashani","year":"2022","unstructured":"Kashani E, Schnidrig D, Gheinani AH, Ninck MS, Zens P, Maragkou T, et al. Integrated longitudinal analysis of adult grade 4 diffuse gliomas with long-term relapse interval revealed upregulation of TGF-\u03b2 signaling in recurrent tumors. Neuro Oncol. 2022;16:noac265.","journal-title":"Neuro Oncol"},{"key":"3474_CR21","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kr\u00e4mer","year":"2014","unstructured":"Kr\u00e4mer A, Green J, Pollard J Jr, Tugendreich S. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics. 2014;30:523\u201330.","journal-title":"Bioinformatics"},{"key":"3474_CR22","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.3892\/ijo.2015.2963","volume":"46","author":"L Annovazzi","year":"2015","unstructured":"Annovazzi L, Caldera V, Mellai M, Riganti C, Battaglia L, Chirio D, et al. The DNA damage\/repair cascade in glioblastoma cell lines after chemotherapeutic agent treatment. Int J Oncol. 2015;46:2299\u2013308.","journal-title":"Int J Oncol"},{"key":"3474_CR23","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen Y, Wang X. MiRDB: An online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48:D127\u201331.","journal-title":"Nucleic Acids Res"},{"key":"3474_CR24","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.3390\/cancers14215227","volume":"14","author":"E Kashani","year":"2022","unstructured":"Kashani E, Vassella E. Pleiotropy of PP2A Phosphatases in Cancer with a Focus on Glioblastoma IDH Wildtype. Cancers (Basel). 2022;14:5227.","journal-title":"Cancers (Basel)"},{"key":"3474_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-023-05967-x","volume":"14","author":"EJ Yun","year":"2023","unstructured":"Yun EJ, Kim D, Kim S, Hsieh JT, Baek ST. Targeting Wnt\/\u03b2-catenin-mediated upregulation of oncogenic NLGN3 suppresses cancer stem cells in glioblastoma. Cell Death Dis. 2023;14:1\u201311.","journal-title":"Cell Death Dis"},{"key":"3474_CR26","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1056\/NEJMoa0909494","volume":"362","author":"L Kappos","year":"2010","unstructured":"Kappos L, Radue EW, O\u2019Connor P, Polman C, Hohlfeld R, Calabresi P, et al. A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis. N Engl J Med. 2010;362:387\u2013401.","journal-title":"N Engl J Med"},{"key":"3474_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0079541","volume":"8","author":"LG Mariotti","year":"2013","unstructured":"Mariotti LG, Pirovano G, Savage KI, Ghita M, Ottolenghi A, Prise KM, et al. Use of the \u03b3-H2AX assay to investigate DNA repair dynamics following multiple radiation exposures. PLoS One. 2013;8:1\u201312.","journal-title":"PLoS One"},{"key":"3474_CR28","doi-asserted-by":"crossref","unstructured":"Lang F., Cornwell J. A., Kaur K., Elmogazy O., Zhang W., Zhang M., et al. Abrogation of the G2\/M checkpoint as a chemosensitization approach for alkylating agents. Neuro Oncol. 2023;26:1\u201314.","DOI":"10.1093\/neuonc\/noad252"},{"key":"3474_CR29","first-page":"1","volume":"10","author":"Z Hu","year":"2020","unstructured":"Hu Z, Mi Y, Qian H, Guo N, Yan A, Zhang Y, et al. A Potential Mechanism of Temozolomide Resistance in Glioma\u2013Ferroptosis. Front Oncol. 2020;10:1\u20139.","journal-title":"Front Oncol"},{"key":"3474_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40170-020-00217-6","volume":"8","author":"KD Tousignant","year":"2020","unstructured":"Tousignant KD, Rockstroh A, Poad BLJ, Talebi A, Young RSE, Taherian Fard A, et al. Therapy-induced lipid uptake and remodeling underpin ferroptosis hypersensitivity in prostate cancer. Cancer Metab. 2020;8:11.","journal-title":"Cancer Metab"},{"key":"3474_CR31","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1038\/s41401-024-01336-2","volume":"45","author":"X Jiang","year":"2024","unstructured":"Jiang X, Yu M, Wang WK, Zhu LY, Wang X, Jin HC, et al. The regulation and function of Nrf2 signaling in ferroptosis-activated cancer therapy. Acta Pharmacol Sin. 2024;45:2229\u201340.","journal-title":"Acta Pharmacol Sin"},{"key":"3474_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-021-04307-1","volume":"12","author":"H Dong","year":"2021","unstructured":"Dong H, Xia Y, Jin S, Xue C, Wang Y, Hu R, et al. Nrf2 attenuates ferroptosis-mediated IIR-ALI by modulating TERT and SLC7A11. Cell Death Dis. 2021;12:1\u201310.","journal-title":"Cell Death Dis"},{"key":"3474_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-024-06558-0","volume":"15","author":"X Li","year":"2024","unstructured":"Li X, Zhang W, Xing Z, Hu S, Zhang G, Wang T, et al. Targeting SIRT3 sensitizes glioblastoma to ferroptosis by promoting mitophagy and inhibiting SLC7A11. Cell Death Dis. 2024;15:1\u201314.","journal-title":"Cell Death Dis"},{"key":"3474_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-022-03657-4","volume":"20","author":"J Su","year":"2022","unstructured":"Su J, Li Y, Liu Q, Peng G, Qin C, Li Y. Identification of SSBP1 as a ferroptosis-related biomarker of glioblastoma based on a novel mitochondria-related gene risk model and in vitro experiments. J Transl Med. 2022;20:1\u201319.","journal-title":"J Transl Med"},{"key":"3474_CR35","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s12253-013-9653-x","volume":"19","author":"Z Jia","year":"2013","unstructured":"Jia Z, Wang K, Zhang A, Wang G, Kang C, Han L, et al. MiR-19a and miR-19b overexpression in gliomas. Pathol Oncol Res. 2013;19:847\u201353.","journal-title":"Pathol Oncol Res"},{"key":"3474_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22062960","volume":"22","author":"E Schnabel","year":"2021","unstructured":"Schnabel E, Knoll M, Schwager C, Warta R, Mock A, Campos B, et al. Prognostic value of microRNA-221\/2 and 17-92 families in primary glioblastoma patients treated with postoperative radiotherapy. Int J Mol Sci. 2021;22:1\u201318.","journal-title":"Int J Mol Sci"},{"key":"3474_CR37","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/neuonc\/nou169","volume":"17","author":"F Zhi","year":"2015","unstructured":"Zhi F, Shao N, Wang R, Deng D, Xue L, Wang Q, et al. Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma. Neuro Oncol. 2015;17:383\u201391.","journal-title":"Neuro Oncol"},{"key":"3474_CR38","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/neuonc\/noae062","volume":"26","author":"M McCord","year":"2024","unstructured":"McCord M, Jamshidi P. Targeting the cell cycle to enhance chemotherapy efficacy in glioblastoma. Neuro Oncol. 2024;26:1097\u20138.","journal-title":"Neuro Oncol"},{"key":"3474_CR39","first-page":"2826","volume":"22","author":"Y Sun","year":"2020","unstructured":"Sun Y, Deng R, Zhang C. Erastin induces apoptotic and ferroptotic cell death by inducing ROS accumulation by causing mitochondrial dysfunction in gastric cancer cell HGC.27. Mol Med Rep. 2020;22:2826\u201332.","journal-title":"Mol Med Rep"},{"key":"3474_CR40","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6634718","volume":"2021","author":"XY Zhou","year":"2021","unstructured":"Zhou XY, Zhang J, Li Y, Chen YX, Wu XM, Li X, et al. Advanced Oxidation Protein Products Induce G1\/G0-Phase Arrest in Ovarian Granulosa Cells via the ROS-JNK\/p38 MAPK-p21 Pathway in Premature Ovarian Insufficiency. Oxid Med Cell Longev. 2021;2021:6634718.","journal-title":"Oxid Med Cell Longev"},{"key":"3474_CR41","doi-asserted-by":"publisher","first-page":"736","DOI":"10.4161\/cc.9.4.10613","volume":"9","author":"AK Freeman","year":"2010","unstructured":"Freeman AK, Dapic V, Monteiro AN. Negative regulation of CHK2 activity by protein phosphatase 2A is modulated by DNA damage. Cell Cycle. 2010;9:736\u201347.","journal-title":"Cell Cycle"},{"key":"3474_CR42","doi-asserted-by":"publisher","first-page":"7529","DOI":"10.1128\/MCB.00447-06","volume":"26","author":"V Leung-Pineda","year":"2006","unstructured":"Leung-Pineda V, Ryan CE, Piwnica-Worms H. Phosphorylation of Chk1 by ATR Is Antagonized by a Chk1-Regulated Protein Phosphatase 2A Circuit. Mol Cell Biol. 2006;26:7529\u201338.","journal-title":"Mol Cell Biol"},{"key":"3474_CR43","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/1878-0261.13488","volume":"17","author":"OV Denisova","year":"2023","unstructured":"Denisova OV, Merisaari J, Huhtaniemi R, Qiao X, Yetukuri L, Jumppanen M, et al. PP2A-based triple-strike therapy overcomes mitochondrial apoptosis resistance in brain cancer cells. Mol Oncol. 2023;17:1803\u201320.","journal-title":"Mol Oncol"},{"key":"3474_CR44","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.7150\/thno.82132","volume":"13","author":"B Qian","year":"2023","unstructured":"Qian B, Che L, Du ZB, Guo NJ, Wu XM, Yang L, et al. Protein phosphatase 2A-B55\u03b2 mediated mitochondrial p-GPX4 dephosphorylation promoted sorafenib-induced ferroptosis in hepatocellular carcinoma via regulating p53 retrograde signaling. Theranostics. 2023;13:4288\u2013302.","journal-title":"Theranostics"},{"key":"3474_CR45","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/onc.2011.339","volume":"31","author":"S Mannava","year":"2012","unstructured":"Mannava S, Omilian AR, Wawrzyniak JA, Fink EE, Zhuang D, Miecznikowski JC, et al. PP2A-B56\u03b1 controls oncogene-induced senescence in normal and tumor human melanocytic cells. Oncogene. 2012;31:1484\u201392.","journal-title":"Oncogene"},{"key":"3474_CR46","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaq1093","volume":"10","author":"O Kauko","year":"2018","unstructured":"Kauko O, O\u2019Connor CM, Kulesskiy E, Sangodkar J, Aakula A, Izadmehr S, et al. PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells. Sci Transl Med. 2018;10:eaaq1093.","journal-title":"Sci Transl Med"},{"key":"3474_CR47","doi-asserted-by":"publisher","first-page":"15717","DOI":"10.3390\/ijms232415717","volume":"23","author":"L Cucinotta","year":"2022","unstructured":"Cucinotta L, Filippone A, Casili G, Lanza M, Bova V, Capra AP, et al. The Pivotal Role of Protein Phosphatase 2A (PP2A) in Brain Tumors. Int J Mol Sci. 2022;23:15717.","journal-title":"Int J Mol Sci"},{"key":"3474_CR48","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.pharep.2017.07.003","volume":"69","author":"L Zhang","year":"2017","unstructured":"Zhang L, Wang H. FTY720 inhibits the Nrf2\/ARE pathway in human glioblastoma cell lines and sensitizes glioblastoma cells to temozolomide. Pharmacol Rep. 2017;69:1186\u201393.","journal-title":"Pharmacol Rep"},{"key":"3474_CR49","first-page":"1915","volume":"16","author":"S Izreig","year":"2016","unstructured":"Izreig S, Samborska B, Johnson RM, Sergushichev A, Ma EH, Lussier C, et al. The miR-17 92 microRNA Cluster Is a Global Regulator of Tumor Metabolism Article The miR-17 92 microRNA Cluster Is a Global Regulator of Tumor Metabolism. CellReports. 2016;16:1915\u201328.","journal-title":"CellReports"},{"key":"3474_CR50","doi-asserted-by":"publisher","first-page":"4478","DOI":"10.3390\/cancers15184478","volume":"15","author":"M Davy","year":"2023","unstructured":"Davy M, Genest L, Legrand C, Pelouin O, Froget G, Castagn\u00e9 V, et al. Evaluation of Temozolomide and Fingolimod Treatments in Glioblastoma Preclinical Models. Cancers (Basel). 2023;15:4478.","journal-title":"Cancers (Basel)"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03474-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03474-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03474-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T02:44:33Z","timestamp":1786934673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03474-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9,5]]}},"alternative-id":["3474"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03474-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.01.16.524069","asserted-by":"object"}]},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Cantonal Ethics Commission of the Canton of Bern (KEK-BE:2018-00663), which waived the requirement for written informed consent. Animal experiments were performed in accordance with the Swiss Federal regulations and were previously approved by the Veterinary Office of the Canton of Bern (number BE68\/2021). The study was performed in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All authors have read and approved of its submission to this journal.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}}]}}